PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2039036
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2039036
Latex Probe Cover Market is estimated to be valued at USD 19.6 Bn in 2026 and is expected to reach USD 28.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 19.6 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.30% | 2033 Value Projection: | USD 28.7 Bn |
Probe covers are consistently used for diagnosis of various diseases such as cardiovascular diseases, urinary tract infection, and others. These probe covers fit tightly over the probe tip and are extended over the entire wand-like projection of the probe. Endocavitary probe should be used along with probe covers since these probes are used for oropharyngeal, vaginal, and rectal examinations. Pathogens such as human papillomavirus (HPV), herpes simplex virus, and other sexually transmitted infections are passed through contact with mucosal surfaces. Probe covers act as protective barrier and prevent the cross infection during ultrasound procedures, which is expected to propel the growth of latex probe cover market over the forecast period.
Guidelines provided by regulatory authorities and other healthcare organizations recommend the use of probe covers for ultrasound procedures, which is expected to drive growth of latex probe cover market over the forecast period. For instance, the European Society of Radiology Ultrasound Working Group published an article on best practice recommendations for infection prevention and control in ultrasound, in November 2017, according to which probe covers should be used adequately, in order to reduce the risk of cross infection during ultrasound procedures.
Furthermore, increasing prevalence of chronic kidney disease is expected to propel growth of the latex probe cover market over the forecast period. For instance, according to the Australian Institute of Health and Welfare, around 1.8 million people were hospitalized due to chronic kidney disease in Australia in 2016-17.